Other small molecule targeted inhibitors of PI3K [45], BCR pathway [46], and BTK [47] also result in depletion or decrease in intracellular levels of Mcl-1 protein in CLL lymphocytes. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.